Exenatide
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
AstraZeneca · Phase 3 · Status n/r · Enrollment 150
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Exenatide
AstraZeneca · Phase 3 · Status n/r · Enrollment 150
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.